Chester County News and Community Website
AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) posted record financial results for both the fourth quarter and full year of 2024, reflecting outstanding revenue growth fueled by its merger with …
Globus Medical Reports Record Sales and Strong Growth in 2024 Read More AUDUBON, PA & REDWOOD CITY, CA — Globus Medical (NYSE: GMED) has announced a definitive agreement to acquire all shares of Nevro Corp. (NYSE: NVRO) in an all-cash transaction worth approximately …
Globus Medical to Acquire Nevro Corp. in Strategic $250 Million Deal Read More AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) has reported impressive preliminary unaudited sales results for the fourth quarter and full year ending December 31, 2024. The medical device company anticipates …
Globus Medical Reports Record Sales Growth for 2024 Read More AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) has unveiled its financial success for the third quarter of 2024, showcasing notable growth driven by strategic acquisitions and product innovations. The …
Globus Medical Reports Robust Q3 2024 Financial Performance and Raises Annual Outlook Read More AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) has announced a significant expansion in its orthopedic trauma product offerings, introducing cutting-edge systems that enhance surgical precision and patient care. Among the …
Globus Medical Expands Orthopedic Trauma Portfolio with Innovative Solutions Read More AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) has launched the ADIRA™ XLIF™ Plate System, marking a significant step in lateral spine surgery. This new product is the first to …
Globus Medical Introduces ADIRA XLIF Plate System for Enhanced Spine Surgery Read More AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) announced robust financial results for the quarter ending June 30, 2024, showing a significant increase in worldwide net sales.
Globus Medical Reports Strong Q2 Results, Boosts Guidance Read More AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ExcelsiusFlex™ robotic navigation platform, tailored for Total Knee …
Globus Medical Gains FDA Clearance for New Knee Surgery Technology Read More AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED), a leader in musculoskeletal solutions, announced a significant increase in worldwide net sales for the quarter ended March 31, 2024, highlighting the …
Globus Medical Reports Strong Sales Growth Post-NuVasive Merger Despite Quarterly Net Loss Read More